Prevent Overestimation of Cannabidiol in Medical Cannabis Potency Testing by GC-FID.

As the medical cannabis industry grows, quality testing becomes more important for consumer protection. Accurate reporting of cannabinoids is highly dependent on GC column selectivity. The selectivity of Rxi®-35Sil MS columns provides complete separation of critical compounds and prevents overestimation of cannabis potency. [ABSTRACT FROM AUTHOR]